Cargando…

Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study

INTRODUCTION: Occlusive portal venous system thrombosis (PVT) is significantly associated with poor outcomes in cirrhotic patients. Nonselective β-blockers (NSBBs) may be associated with the development of PVT. However, the role of NSBBs in progressing thrombosis remains unclear. METHODS: Forty-thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiangbo, Xu, Shixue, Primignani, Massimo, De Stefano, Valerio, He, Yanglan, Yi, Fangfang, Guo, Xiaozhong, Valla, Dominique, Qi, Xingshun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140745/ https://www.ncbi.nlm.nih.gov/pubmed/32076942 http://dx.doi.org/10.1007/s12325-020-01250-z

Ejemplares similares

Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis
por: He, Yanglan, et al.
Publicado: (2021)

The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018)

Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence
por: Xu, Xiangbo, et al.
Publicado: (2019)

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
por: Zampino, Rosa, et al.
Publicado: (2018)

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis
por: Wang, Le, et al.
Publicado: (2021)

Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review
por: Xu, Shixue, et al.
Publicado: (2021)

Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients
por: An, Yang, et al.
Publicado: (2021)

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis
por: Zhang, Yiyan, et al.
Publicado: (2023)

An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty
por: Qi, Xingshun, et al.
Publicado: (2016)

Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study
por: Wang, Le, et al.
Publicado: (2022)

Approach to different thrombolysis techniques and timing of thrombolysis in the management of portal vein thrombosis in cirrhotic patients
por: Primignani, Massimo, et al.
Publicado: (2023)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Is the use of non-selective beta-blockers necessary in cirrhotic patients with small varices?
por: Qi, Xingshun, et al.
Publicado: (2014)

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis
por: Wang, Le, et al.
Publicado: (2020)

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2014)

No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis
por: Zheng, Kexin, et al.
Publicado: (2020)

Clinical significance of neutrophil extracellular traps biomarkers in thrombosis
por: Xu, Xiangbo, et al.
Publicado: (2022)

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography
por: McDonald, Natasha, et al.
Publicado: (2017)

Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis
por: Ren, Wenhua, et al.
Publicado: (2020)

Management of Portal Vein Thrombosis in Cirrhotic Patients
por: Amitrano, Lucio, et al.
Publicado: (2009)

Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies
por: Qi, Xingshun, et al.
Publicado: (2015)

Non-cirrhotic portal vein thrombosis – therapeutic challenge
por: Sarquis, Lucas Mansano, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis
por: Qi, Xingshun, et al.
Publicado: (2012)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis
por: Dai, Junna, et al.
Publicado: (2015)

Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Lin, Hanyang, et al.
Publicado: (2022)

Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients
por: Qi, Xingshun, et al.
Publicado: (2016)

Changes in transient elastography in early cirrhotic patients after receiving nonselective B‐blocker for primary variceal bleeding prophylaxis: Three‐month follow up
por: Piyachaturawat, Panida, et al.
Publicado: (2018)

Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis
por: Chen, Hui, et al.
Publicado: (2015)

Successful Pharmacotherapy for Multiple Acute Decompensation Events in a Cirrhotic Patient with Acute-on-chronic Liver Failure: A Case Report
por: Xu, Xiangbo, et al.
Publicado: (2018)

Natural Course of Nonmalignant Partial Portal Vein Thrombosis in Cirrhotic Patients
por: Girleanu, Irina, et al.
Publicado: (2014)

Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)

Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients
por: Zakko, Alan, et al.
Publicado: (2018)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis
por: Lai, Mason, et al.
Publicado: (2023)

Early thrombolysis combined with anticoagulation and antibiotics for acute portal venous system thrombosis secondary to intra-abdominal infection
por: Gao, Fangbo, et al.
Publicado: (2023)

A good response to glucocorticoid for Henoch–Schönlein purpura with abdominal pain and gastrointestinal bleeding in an adult: A CARE case report
por: Yi, Fangfang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3586up5q3a1m285rd1gd3cflq0